Producing Human Brain-Derived Neurotrophic Factor in E. coli
Author Information
Author(s): Spaccapaniccia Elisa, Cazzorla Tiziano, Rossetti Daniela, De Simone Lucio, Antonangeli Maria Irene, Antonosante Andrea, Galli Francesca, Cattani Franca, Maffei Mariano, Martin Franck
Primary Institution: Dompé Farmaceutici S.p.A.
Hypothesis
Can a new protocol for producing recombinant human brain-derived neurotrophic factor (rhBDNF) in E. coli be established?
Conclusion
The study successfully developed a high-yield process for producing and purifying rhBDNF in E. coli, which could facilitate its use in clinical applications.
Supporting Evidence
- The new protocol allows for the production of rhBDNF at high yields.
- More than 50% of the precursor can be refolded successfully.
- The process is scalable for GMP-grade material production.
- Trypsin was effectively used to cleave the pro-peptide from rhBDNF.
- The final product showed high purity and biological activity.
Takeaway
Scientists figured out how to make a special brain protein in bacteria, which can help treat brain problems. This new way makes a lot of the protein quickly and easily.
Methodology
The study involved cloning a synthetic gene for rhBDNF into an E. coli expression vector, followed by fermentation, protein refolding, and purification using chromatographic techniques.
Limitations
The enzymatic digestion process may lead to the generation of hyperdigested variants of the protein.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website